Elsevier

Phytomedicine

Volume 92, November 2021, 153755
Phytomedicine

Targeting Nrf2/Keap1 signaling pathway by bioactive natural agents: Possible therapeutic strategy to combat liver disease

https://doi.org/10.1016/j.phymed.2021.153755Get rights and content

Highlights

  • Nrf2 activators exhibited promising effects in resisting a variety of liver diseases.

  • Roles of phytochemicals in activating Nrf2 and mitigate liver injury were summarized.

  • Studies in each aspect of investigations: clinical, in vivo, and in vitro studies were admitted.

Abstract

Background

Nuclear factor erythroid 2-related factor (Nrf2), a stress-activated transcription factor, has been documented to induce a defense mechanism against oxidative stress damage, and growing evidence considers this signaling pathway a key pharmacological target for the treatment of liver diseases.

Purpose

The present review highlights the role of phytochemical compounds in activating Nrf2 and mitigate toxicant-induced stress on liver injury.

Methods

A comprehensive search of published articles was carried out to focus on original publications related to Nrf2 activators against liver disease using various literature databases, including the scientific Databases of Science Direct, Web of Science, Pubmed, Google, EMBASE, and Scientific Information (SID).

Results

Nrf2 activators exhibited promising effects in resisting a variety of liver diseases induced by different toxicants in preclinical experiments and in vitro studies by regulating cell proliferation and apoptosis as well as an antioxidant defense mechanism. We found that the phytochemical compounds, such as curcumin, naringenin, sulforaphane, diallyl disulfide, mangiferin, oleanolic acid, umbelliferone, daphnetin, quercetin, isorhamnetin-3-O-galactoside, hesperidin, diammonium glycyrrhizinate, corilagin, shikonin, farrerol, and chenpi, had the potential to improve the Nrf2-ARE signaling thereby combat hepatotoxicity.

Conclusion

Nrf2 activators may offer a novel potential strategy for the prevention and treatment of liver diseases. More extensive studies are essential to identify the underlying mechanisms and establish future therapeutic potentials of these signaling modulators. Further clinical trials are warranted to determine the safety and effectiveness of Nrf2 activators for hepatopathy.

Introduction

The liver is one of the vital organs representing almost 2.5% of the overall body weight in an adult human (Molina and DiMaio, 2012). It maintains homeostasis by regulating the biochemical pathways involving energy metabolism, providing immunity and nutrition to other organs (Godoy et al., 2013). The liver, located at the upper right part of the abdominal cavity, is connected to the hepatic artery and hepatic portal vein and receives about 25% of the cardiac output at rest (Eipel et al., 2010). It filters the blood containing nutrients, toxins, and other substances from the gastrointestinal tract or the duodenum through the hepatic portal vein (Hill and Nassrallah, 2018). Almost half of the body's lymph is produced in the liver, which cleanses the blood through portal veins or the blood from the hepatic arteries (Ohtani and Ohtani, 2008).

The liver holds the name "Nutritional hub" for its majority functions to metabolize carbohydrates, protein, and fat, detoxify toxic elements, and secrete bile juice (Rui, 2014). It helps maintain extra glucose that can be stored as glycogen and released into the bloodstream as ready glucose when needed. The liver can intend to make glucose from glycerol (obtained by breakdown of triglycerides) or dietary sugars like fructose and galactose by the process of gluconeogenesis when the body is deprived of glucose and glycogen (Kumar et al., 2005; Nguyen et al., 2008). The liver also plays a major role in the deamination process to remove the nitrogen-containing amino group (ammonia), which is potentially toxic to the body and serves as a source of some of the proteins involved in blood clotting (Kumar et al., 2004). The removed ammonia is then converted to urea by the liver and is eliminated out of the body (Sukalingam et al., 2018).

The liver resides a major site for burning fatty acids into ketone bodies that are stored in the liver's mitochondrial matrix which can be used by the body at the time of glucose deprivation (Ganesan et al., 2017; Sharmila Banu et al., 2009b). The liver also aids in the production of bile juice using phospholipid and cholesterol that serve as a reservoir of vitamins (Chow et al., 2017; Sharmila Banu et al., 2009a). More importantly, the liver metabolizes alcohol with the NAD-dependent enzyme aldehyde dehydrogenase 2 and alcohol dehydrogenase by nontoxic oxidative degradation of alcohol to acetaldehyde followed by oxidation of acetaldehyde to acetate (Kumar et al., 2007; Muzio et al., 2012; Wang et al., 2020). Disturbances in any of these biochemical reactions cause acute or chronic liver injury leading to the release of inflammatory signals from liver immune cells (e.g., dendritic cells, kupfer cells) with the release of immune mediators, the cytokines/chemokines (Muzio et al., 2012). The prolonged exposure to these inflammatory mediators turns up oxidative stress environment and may trigger apoptotic pathways (Djordjevic et al., 2010; Yu et al., 2009). This kind of proinflammatory cytokine storm leading to chronic liver inflammation has been reported to be commonly diagnosed in alcoholic/nonalcoholic steatohepatitis patients (Severi et al., 2010). They also tend to develop certain immune/metabolic compromises, including high neutrophil count, fever, insulin resistance, and lipid metabolism (Djordjevic et al., 2010; Severi et al., 2010).

Being described as the “laboratory of the body”, the liver plays a chief role in biotransformation and excretion, beside synthesizing hormones, clotting factors, and immune factors (Godoy et al., 2013). Biotransformation helps in the excretion of both exogenous and endogenous substances (Bogdanos et al., 2013). Endogenous substances like reactive oxygen species (ROS) are formed as the natural by-product of cellular activities (Ray et al., 2012). For example, the liver's immune cells, known as Kupfer cells, participate in phagocytosis to destroy the cellular debris or invading bacteria and produces ROS (Bogdanos et al., 2013).

Nuclear factor erythroid 2-related factor 2 (Nrf2) is a transcription factor that is activated under electrophilic or oxidative stress, thereby regulating its downstream antioxidant genes (Jayasuriya et al., 2020; Kobayashi et al., 2006). The activation of Nrf2 is constantly inhibited by its negative regulator Kelch-like ECH-associated protein 1 (Keap1) (Jayasuriya et al., 2020). Under a stress environment, Nrf2 binds to the antioxidant response elements (AREs) and activates downstream targets such as Heme Oxygenase-1 (HO-1), Catalase (CAT), Glutathione Peroxidase (GPx), Superoxide Dismutase (SOD), NADPH-Quinone Oxidoreductase-1 (NQO-1), and Glutamate Cysteine Ligase (GCL) (Lee and Johnson, 2004; Vomhof-Dekrey and Picklo, 2012). Studies have reported the functions of these genes, including catabolizing heme, scavenging superoxide, and proved the Nrf2-mediated gene regulation in enhancing the antioxidant status.

Section snippets

Nrf2-ARE signaling

As a member of cap 'n' collar (CNC) basic leucine zipper protein, Nrf2 binds to ARE of the target by recruiting a small Maf family of transcription factors (Rushmore et al., 1991). Nrf2 level is maintained under the homeostatic condition by Keap1 mediated Cullin3-RING box1 (Cul3-Rbx1) binding, which presents ubiquitination and subsequent proteasomal degradation (Villeneuve et al., 2010). However, its activation under multiple stress environments provides cryoprotection to cells by upregulating

Role of Nrf2 against liver diseases

Numerous scientific reports describe the role of Nrf2 activators that mitigates response against hepatotoxicants. The data presented in this review have been collected from various literature databases, including the scientific Databases of Science Direct, Web of Science, Pubmed, Google, EMBASE, and Scientific Information (SID). The survey included the keywords such as liver, Nrf2, liver diseases, Nrf2 activators, liver diseases and Nrf2 activators, Nrf2 activators against hepatotoxicants, Nrf2

Discussion and future prospects

In this review, we have analyzed the pieces of literature on Nrf2 activators and their mode of action against hepatotoxic agents, to date. Research in the field of Nrf2 is recently increasing, especially in response to phytocompounds. To note, more recent studies on pharmacological activation of Nrf2 have focused on experimental research rather than basic research. It is also evident that many Nrf2 activators are on pre-clinical and clinical research for various chronic diseases including

Conclusion

In conclusion, our analysis has revealed the growing interest and experimental research on pharmacological activation of Nrf2 activation through phytocompounds. Activation of the Nrf2 signaling pathway is an established mechanism for reducing oxidative stress-mediated hepatotoxicity. More extensive studies are essential to identify the underlying mechanisms and establish future therapeutic potentials of these signaling modulators. Further clinical trials are warranted to determine the safety

Declaration of Competing Interest

We wish to confirm that there are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome.

Acknowledgment

One of the authors, R.J. acknowledges the Council of Scientific and Industrial Research (CSIR), New Delhi, India, for the award of Senior Research Fellowship (File No.: 09/1045(11089)/2020-EMR-I).

Funding

This project is jointly supported by two grants (project code: UIC202007 and UIC202107) from BNU-HKBU United International College and one research grant from Guangdong Education Bureau (Project code: R5201911).

CRediT authorship contribution statement

Ravichandran Jayasuriya: Conceptualization, Data curation, Writing – original draft, Writing – review & editing. Umapathy Dhamodharan: Conceptualization, Writing – review & editing. Daoud Ali: Conceptualization, Writing – review & editing. Kumar Ganesan: Conceptualization, Writing – review & editing. Baojun Xu: Conceptualization, Writing – review & editing, Supervision. Kunka Mohanram Ramkumar: Conceptualization, Writing – review & editing, Supervision.

References (167)

  • C. Feng et al.

    Diammonium glycyrrhizinate, a component of traditional Chinese medicine Gan-Cao, prevents murine T-cell-mediated fulminant hepatitis in IL-10- and IL-6-dependent manners

    Int. Immunopharmacol.

    (2007)
  • N. Gan et al.

    Sulforaphane protects microcystin-LR-induced toxicity through activation of the Nrf2-mediated defensive response

    Toxicol. Appl. Pharmacol.

    (2010)
  • K. Ganesan et al.

    Vitexin restores pancreatic β-cell function and insulin signaling through Nrf2 and NF-κB signaling pathways

    Eur. J. Pharmacol.

    (2020)
  • S. Gao et al.

    Curcumin attenuates arsenic-induced hepatic injuries and oxidative stress in experimental mice through activation of Nrf2 pathway, promotion of arsenic methylation and urinary excretion

    Food Chem. Toxicol.

    (2013)
  • C.E. Guerrero-Beltran et al.

    Protective effect of sulforaphane against oxidative stress: recent advances. Experimental and toxicologic pathology : official journal of the Gesellschaft fur

    Toxikol. Pathol.

    (2012)
  • S.Z. Hou et al.

    Ameliorative effects of diammonium glycyrrhizinate on inflammation in focal cerebral ischemic-reperfusion injury

    Brain Res.

    (2012)
  • H.C. Huang et al.

    Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription

    J. Biol. Chem.

    (2002)
  • A.K. Jain et al.

    Phosphorylation of tyrosine 568 controls nuclear export of Nrf2

    J. Biol. Chem.

    (2006)
  • R. Jayasuriya et al.

    Role of Nrf2 in MALAT1/HIF-1alpha loop on the regulation of angiogenesis in diabetic foot ulcer

    Free Radic. Biol. Med.

    (2020)
  • J. Jin et al.

    Role of Nrf2 activation and NF-kappaB inhibition in valproic acid induced hepatotoxicity and in diammonium glycyrrhizinate induced protection in mice

    Food Chem. Toxicol.

    (2014)
  • S. Kalayarasan et al.

    Diallyl sulfide enhances antioxidants and inhibits inflammation through the activation of Nrf2 against gentamicin-induced nephrotoxicity in Wistar rats

    Eur. J. Pharmacol.

    (2009)
  • G. Kumar et al.

    Hepatoprotective activity of trianthema portulacastrum L. against paracetamol and thioacetamide intoxication in albino rats

    J. Ethnopharmacol.

    (2004)
  • I.C. Lee et al.

    The involvement of Nrf2 in the protective effects of diallyl disulfide on carbon tetrachloride-induced hepatic oxidative damage and inflammatory response in rats

    Food Chem. Toxicol.

    (2014)
  • M. Li et al.

    Discovery of Keap1-Nrf2 small-molecule inhibitors from phytochemicals based on molecular docking

    Food Chem. Toxicol.

    (2019)
  • X. Li et al.

    Corilagin, a promising medicinal herbal agent

    Biomed. Pharmacother.

    (2018)
  • Y. Li et al.

    Acute and sub-chronic oral toxicity studies of hesperidin isolated from orange peel extract in Sprague Dawley rats

    Regul. Toxicol. Pharmacol.

    (2019)
  • J. Liu

    Pharmacology of oleanolic acid and ursolic acid

    J. Ethnopharmacol.

    (1995)
  • S. Liu et al.

    Heme oxygenase-1 mediates the protective role of quercetin against ethanol-induced rat hepatocytes oxidative damage

    Toxicol. In Vitro

    (2012)
  • H. Lou et al.

    Naringenin protects against 6-OHDA-induced neurotoxicity via activation of the Nrf2/ARE signaling pathway

    Neuropharmacology

    (2014)
  • H. Lv et al.

    Daphnetin-mediated Nrf2 antioxidant signaling pathways ameliorate tert-butyl hydroperoxide (t-BHP)-induced mitochondrial dysfunction and cell death

    Free Radic. Biol. Med.

    (2017)
  • M.R. Mohamed et al.

    Umbelliferone and daphnetin ameliorate carbon tetrachloride-induced hepatotoxicity in rats via nuclear factor erythroid 2-related factor 2-mediated heme oxygenase-1 expression

    Environ. Toxicol. Pharmacol.

    (2014)
  • G. Muzio et al.

    Aldehyde dehydrogenases and cell proliferation

    Free Radic. Biol. Med.

    (2012)
  • T. Nagano et al.

    New curcuminoids isolated from Zingiber cassumunar protect cells suffering from oxidative stress: a flow-cytometric study using rat thymocytes and H2O2

    Jpn. J. Pharmacol.

    (1997)
  • T. Nguyen et al.

    The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress

    J. Biol. Chem.

    (2009)
  • B.B. Aggarwal et al.

    Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers

    Br. J. Pharmacol.

    (2013)
  • B.B. Aggarwal et al.

    Curcumin: the Indian solid gold

    Adv. Exp. Med. Biol.

    (2007)
  • M.L. Aggarwal et al.

    Systematic and comprehensive investigation of the toxicity of curcuminoidessential oil complex: a bioavailable turmeric formulation

    Mol. Med. Rep.

    (2016)
  • O. Aguiar Jr et al.

    List of contributors

  • N.S. Alrawaiq et al.

    A review of flavonoid quercetin: metabolism, bioactivity and antioxidant properties

    Int. J. Pharmtech. Res.

    (2014)
  • E. Ang et al.

    Mangiferin attenuates osteoclastogenesis, bone resorption, and RANKL-induced activation of NF-kappaB and ERK

    J. Cell. Biochem.

    (2011)
  • M. Ashrafizadeh et al.

    Curcumin activates the Nrf2 pathway and induces cellular protection against oxidative injury

    Curr. Mol. Med.

    (2020)
  • A.N. Assimopoulou et al.

    Radical scavenging activity of alkanna tinctoria root extracts and their main constituents, hydroxynaphthoquinones

    Phytother. Res.

    (2005)
  • S.H. Baek et al.

    Protective effects of an extract of young radish (Raphanus sativus L) cultivated with sulfur (sulfur-radish extract) and of sulforaphane on carbon tetrachloride-induced hepatotoxicity

    Biosci. Biotechnol. Biochem.

    (2008)
  • L. Baird et al.

    The cytoprotective role of the Keap1-Nrf2 pathway

    Arch. Toxicol.

    (2011)
  • E. Bhakkiyalakshmi et al.

    Therapeutic potential of pterostilbene against pancreatic beta-cell apoptosis mediated through Nrf2

    Br. J. Pharmacol.

    (2014)
  • D.P. Bogdanos et al.

    Liver immunology

    Compr. Physiol.

    (2013)
  • G.B. Bubols et al.

    The antioxidant activity of coumarins and flavonoids

    Mini Rev. Med. Chem.

    (2013)
  • D.V. Chartoumpekis et al.

    Nrf2 prevents Notch-induced insulin resistance and tumorigenesis in mice

    JCI Insight

    (2018)
  • Diallyl disulfide (Registry No.: 2179-57-9)

    (2021)
  • L. Chen et al.

    Intracellular signaling pathways of inflammation modulated by dietary flavonoids: the most recent evidence

    Crit. Rev. Food Sci. Nutr.

    (2018)
  • Cited by (36)

    View all citing articles on Scopus
    View full text